Urethritis in men has been categorized historically as gonococcal or nongonococcal (NGU). The major pathogens causing NGU are Chlamydia trachomatis and Ureaplasma urealyticum. Trichomonas vaginalis may be involved occasionally. In up to one-half of cases, an etiologic organism may not be identified In this review we present recent advances in the diagnosis and management of NGU and discuss how they may be applied in a variety of clinical settings, including specialized STD clinics and primary health care practices. In particular, the development of the noninvasive urine-based nucleic acid amplificatio tests may warrant rethinking of the traditional classificatio of urethritis as gonococcal urethritis or NGU. Diagnostics for Chlamydia are strongly recommended because etiologic diagnosis of chlamydial urethritis may have important public health implications, such as the need for partner referral and reporting. A single 1-g dose of azithromycin was found to be therapeutically equivalent to the tetracyclines and may offer the advantage of better compliance.
Urethritis is defined as the presence of leukorrhea and ureand recommended laboratory tests for acute NGU, the etiology thral inflammation [1] . It is clinically characterized by disand management of recurrent NGU, and partner notification charge of mucoid or purulent material and by dysuria. Urethritis strategies. We also review the rationale for changes proposed has been traditionally differentiated as gonococcal or nongonoin the 1998 STD treatment guidelines and discuss how these coccal urethritis (NGU) as the basis for treatment strategies. may be applied in a variety of clinical settings, including speFrom a clinical management perspective, further etiologic difcialized STD clinics and primary health care practices. ferentiation of NGU has not been possible technically. A number of different organisms have been associated with NGU. Chlamydia trachomatis was long considered to be the cause of the largest subgroup of diagnosable cases of NGU, followed Methods by Ureaplasma species [2, 3] . However, identification of specific NGU pathogens is not routinely pursued since the recom-A search of the literature from 1992 to 1996 was conducted mended therapies against Chlamydia species and the other with the MEDLINE 2000 computerized database of the U.S. causes of NGU are similar [4] .
National Library of Medicine. The terms urethritis (as subject) A background article concerning NGU was last prepared for and NGU, Chlamydia urethritis, and treatment (as key words) the sexually transmitted disease (STD) treatment guidelines were searched for in titles and abstracts. Two hundred and five published in 1982 by the Centers for Disease Control and citations were found. The search was then limited to articles Prevention. At that time, treatment for chlamydial infection in the English language with abstracts and concerning human was the major focus of discussion [4] . In 1985 In , 1989 subjects; this reduced the number of citations to 114. Citations this topic was considered in the background articles concerning were then selected from this group on the basis of clinical Chlamydia. The rapid changes in STD epidemiology and the orientation and methodology (i.e., study design, number of development of new diagnostic tests and new therapeutics warsubjects, selection criteria, and sampling design) and considerrant a comprehensive review of this literature.
ation of etiologic and/or management issues. In this article we review the recent literature on diagnosis
We included only those studies that evaluated for multiple and treatment of NGU, focusing on the etiology, treatment, etiologies of NGU. For example, studies of the epidemiology and treatment of chlamydial urethritis were not included, as they are addressed in the background article on Chlamydia for the 1998 STD treatment guidelines. Additional citations from Results of urethral swabs from men with NGU were published in 1981 [20] . The controversy surrounding its pathogenicity in cases of
Etiology of NGU
urethritis is due to the numerous failed attempts to isolate M. genitalium from men with NGU [9, 10, 21] . The advent of In reviewing the literature, we identified six articles [5 -10] and one letter [11] that evaluated the etiology of NGU, with PCR testing has enabled investigators to detect small quantities of M. genitalium DNA [22] . M. genitalium was found to be studies including large numbers of men (52 £ n £ 452) and using more sensitive and specific diagnostic techniques than the pathogen responsible in 15% -25% of NGU cases by PCR testing [7, 9, 10, 11] . In the recent case-control studies rewere previously available. Results of five of these studies are listed in table 1. We also included three additional articles [12 - viewed, M. genitalium was isolated significantly more frequently in the symptomatic NGU cases than in the nonurethritis 14] from earlier time periods or with a more limited etiologic focus to expand information presented on Trichomonas vagi-(control) cases [9 -11] . M. genitalium was not isolated from anatomical sites other than the urethra, such as the throat or nalis urethritis.
The more recently available nucleic acid amplification techrectum. The investigators in these studies concluded that Mycoplasma was likely to be a cause of NGU. Nevertheless, these niques employed in these studies for diagnosis of chlamydia infection have a much higher sensitivity and specificity than investigations were based only on cross-sectional studies and on isolated case reports. Therefore, until more data are availcell culture for diagnosis of the etiology of NGU [15 -17] . For example, in the study by Jaschek et al., cell culture, once able, the relationship between M. genitalium and NGU cannot be considered causal. considered the ''gold standard'' for the diagnosis of chlamydial infection, detected only 68% of Chlamydia-positive urethral T. vaginalis, a protozoan parasite, infects the urogenital tract and is recognized as a common cause of urogenital disease, samples, compared with a 95% detection rate by the urine PCR test [16] .
particularly among infected women [23, 24] . Traditional expert opinion cites that infected men are usually asymptomatic and Surprisingly, Chlamydia was found to account for a relatively small proportion of cases of NGU. In the three largest that morbidity arises primarily from infection of their sex partners. However, the lack of a sensitive test for T. vaginalis in studies, all of which predominantly involved subjects from STD clinics and the use of standardized case definitions for most clinical settings has prevented diagnosis of trichomoniasis as one of the etiologies of urethritis [25] . T. vaginalis may play NGU, chlamydia infection was found in 19% -31% of patients (table 1) [5 -7] . In the largest study in which etiology was a greater role in the etiology of NGU than previously suspected. Borchardt et al. found the prevalence of T. vaginalis to be determined as part of a multicenter treatment trial, only 15% of NGU was chlamydial and regional variation was noted; the 12% when utilizing the InPouch TV culture system (BioMed Diagnostics, San Jose, CA) and only 3% when utilizing the lowest rates were in the Northwest, where a Chlamydia-control program has been in place since 1988 [18, 19] . In the same traditional wet-mount-examination method in a cross-sectional study of 204 men examined at an STD clinic [8] . This study three studies, Ureaplasma urealyticum was detected in 9% -42% of cases. Therefore, even under the best of circumstances, illustrates the poor sensitivity of the traditional wet-mount test for trichomoniasis in males. up to two-thirds of gram stain -documented NGU is not due to these two organisms. These findings have led to the considerWith use of modified Diamond's culture medium, Krieger et al. recovered T. vaginalis from urethral swab and first-voidation of other possibilities.
Mycoplasma genitalium is a recently characterized, slowly urine specimens from 22% of 147 men who had sexual exposure to trichomoniasis and from 6% of 300 randomly selected growing organism. The first reports of its isolation in cultures men presenting to an STD clinic [13] . T. vaginalis was isolated urethra of 16% of men with neither urethral discharge nor microscopically evident urethritis. from 18% of 123 men with nonchlamydial NGU, 11% of 82 men with gonococcal or chlamydial urethritis, and 8% of 242 men without urethritis.
Etiologic Diagnosis
Hoosen et al. identified T. vaginalis, by means of culture with modified Diamond's medium and by wet mount of urethral Chlamydia. Until the recent development of nucleic acidbased diagnostic tests, tissue culture of urethral swab speciswabs, in 14.7% of 55 male patients with persistent urethritis [14] . These rates of trichomonas NGU, which are higher than mens was the ''gold standard'' for diagnosing chlamydial infection. Problems with this method involve patient discomfort, previously reported, suggest that trichomoniasis could be a cause of acute and persistent urethritis that does not respond expense, labor, strict transport requirements, and time to completion of test (up to 72 hours). In addition, there appears to to traditional antimicrobial therapy. Although popular belief posits that most trichomonas NGU cases resolve spontaneously be a difference in culture sensitivity between the male urethral and female endocervical specimens (50% -85% vs. 70% -85%, by 2 weeks without treatment, one study documented spontaneous resolution in only 36% of 20 untreated asymptomatic men respectively) [16, 27, 28] . This discrepancy has been postulated to be due to the less efficient sampling of the male urethra. A who remained sexually abstinent during a mean of 16 days [12, 26] .
smaller swab is used and the urethra has a smaller surface area to be sampled. Despite the improved diagnostic capabilities, the proportion of NGU cases without an identified etiology has been increasUrine-based diagnostic tests decrease costs and time to test completion. They also prevent the discomfort associated with ing. Janier et al. found 20% of patients with NGU to be infected with indeterminate pathogens (Haemophilus parainfluenzae, urethral sampling and may thereby improve patients' acceptance of diagnostic testing. The urine EIA, although promising group B streptococci, Gandnerella vaginalis, Mycoplasma hominis, other Streptococcus species, Staphylococcus aureus, when released, proved to have an unacceptably low sensitivity of only 53% for detecting Chlamydia in first-void urine, as and Candida albicans), while no pathogens were recovered in 35% of the NGU cases [7] . In a multicenter study using cell compared to urethral cell cultures [29, 30] . Urine-based direct fluorescent antibody (DFA) tests appear to be more effective. culture of urethral swabs for isolation of Chlamydia, seven of the participating centers isolated Chlamydia from õ20% of In one study, a urine DFA test appeared to be more sensitive than a urethral DFA test, regardless of time after voiding (90% men with acute NGU, whereas only two centers isolated Chlamydia from ú30% of men presenting with acute NGU [5] .
sensitivity via urine DFA test vs. 83% sensitivity via urethral DFA test) [31] . This contrasts with previous studies using cell culture of urethral swabs, in which C. trachomatis accounted for 35% -45% DNA amplification testing via both urethral and urine specimens has superior sensitivity and specificity in comparison of acute NGU cases [3] . Five of the six studies reviewed that examined NGU etiology found C. trachomatis in õ35% of with all other available tests for etiologic diagnosis of NGU [15 -17, 27, 28, 31, 32] . As previously mentioned, M. genicases. No identified NGU etiology has been particularly pronounced in areas with Chlamydia-control programs.
talium has been consistently detected from the urethra only by PCR techniques [9, 10, 21, 22] . In a study looking at chlamydia infection among sexual contacts, PCR identified 50% more infected individuals than culture, with a greater increase in the Laboratory Diagnosis yield of positive tests among males than among females [28] . The frequency of isolation of Chlamydia from male partners Gram staining. Although gram staining is still widely used to diagnose urethritis, the question arises as to the relevance of infected females rose from 42% by culture to 68% by PCR.
Half of the men in this study were asymptomatic, making PCR of the microscopic definition of urethritis if new diagnostic capabilities can isolate STD pathogens in asymptomatic men an attractive diagnostic method for etiologic identification of asymptomatic urethritis, especially with use of urine speciand/or in men who may not meet the microscopic criteria for NGU. Recent studies evaluating the etiology and treatment of mens. The disadvantage of any nonculture test is the inability to NGU have continued to rely on gram staining to define this syndrome and to identify gram-negative diplococci [5, 7, 9 - differentiate active infection from cured infection. For example, after bacterial lysis, DNA fragments may persist and give a 11]. One of these studies evaluated the utility of urethral-smear gram staining and leukocyte count of centrifuged first-void false-positive result. A study of 33 adolescent females with chlamydial infection diagnosed by both PCR and ligase chain urine to diagnose urethritis in men presenting to an STD clinic [7] . Etiologic results were obtained in all cases, regardless of reaction (LCR) urine tests showed that all follow-up PCR and LCR tests were negative by 15 days following therapy [33] . symptoms and smear results. At least one STD pathogen was isolated from the urethra of 46% of men with urethral discharge However, the time period for this ''carryover'' is still not well defined. This disadvantage must be weighed against the advanbut who did not meet the microscopic definition of urethritis. In addition, at least one STD pathogen was isolated from the tage of patients' acceptance of a urine-based test over urethral S69 CID 1999 is not recommended except in a referral or research setting. 
Diagnostic and Management Strategies
Documentation of urethritis is essential when patients present with dysuria, burning, and frequency, since these symptoms Treatment may be due to etiologies other than treatable STDs. If mucoid or purulent discharge is not evident on examination, then either Stamm et al. compared a single 1-g dose of azithromycin to a 7-day course of doxycycline in a randomized, double-blind, a positive leukesterase test (LET) of first-void urine or a gram stain demonstrating §5 WBCs per high-powered field (hpf) multicenter trial of empirical treatment for NGU [5] (table 3) . These patients were also evaluated for infection by culture for can document the syndrome. The gram stain offers the opportunity to differentiate gonococcal urethritis from NGU. Gram C. trachomatis and U. urealyticum (Neisseria gonorrhoeae was excluded by culture). Clinical cure rates were comparable stains are not available in most clinical practice settings such as ambulatory care clinics, offices, and emergency departments.
among the 248 patients in the azithromycin-treated group (90%) vs. the 123 in the doxycycline-treated groups (89%). Therefore, clinicians must rely on documentation of discharge by examination or by a positive LET to fulfill the criteria for Patients were reevaluated for infection at 2 and 5 weeks after study enrollment. Clinical cure rates were similar in the two urethritis. This is a problem because of clinicians' desire to establish objectively the presence of urethritis and an etiologic groups when stratified for presence or absence of C. trachomatis and U. urealyticum prior to treatment. Adverse reactions, diagnosis. There is also a clinical and public health imperative to provide effective treatment at the time of the visit. mostly gastrointestinal, were mild to moderate and occurred in 23% of azithromycin-treated and 29% of doxycycline-treated New etiologic diagnostic tests with very high sensitivities and specificities have demonstrated that asymptomatic urethripatients. A lower dose of azithromycin did not prove effective for tis is more common than previously suspected. Table 2 lists all the studies reviewed that distinguish urethritis etiologies in the treatment of NGU. In a study of 11 men who were administered a single 500-mg dose of azithromycin for treatment of terms of symptomatology and/or microscopic findings. Between 5% and 58% of urethritis cases in these citations were NGU, only 4 were cured, the therapy of 3 failed, and 4 were lost to follow-up by 4 weeks after treatment [32] . asymptomatic and between 5% and 38% of cases had microscopic findings of õ5 polymorphonuclear leukocytes (PMNs)
Although the theoretical advantage of a single-dose treatment for NGU appears obvious, studies comparing rates of per hpf on a gram stain or õ10 WBCs/hpf in a spun urine specimen. How do we then define urethritis if standard definiboth symptomatic and etiologic cure of NGU do not prove an advantage over a 7-day course of doxycycline [5, 35 -37] public health sector, where funds are limited. In a 1995 study at 4 weeks' follow-up, with a 100% cure rate for chlamydial urethritis and 63% for ureaplasma urethritis [6] . An older study by Stamm et al. [5] , the cost of azithromycin therapy was 10 times that of doxycycline.
examining the prevalence of tetracycline-resistant U. urealyticum revealed persistence of NGU in three of six men infected Other therapeutics do not appear to offer any advantage over doxycycline or azithromycin for the treatment of NGU.
with Ureaplasma strains for which the MICs were §256 mg/mL at 6 -8 days after initiation of treatment with minocyMinocycline was shown to be as effective as doxycycline in curing both chlamydial NGU and nonchlamydial NGU in a cline [42] . This is an important point to keep in mind, since the prevalence of nongonococcal nonchlamydial pathogens in randomized controlled trial [6] . Both treatment courses were 7 days. Although adverse effects occurred more frequently in the cases of NGU is increasing. doxycycline treatment group than in the minocycline treatment group in this study, earlier studies documented severe adverse effects, including vestibular dysfunction with the administraDiscussion tion of minocycline [38, 39] . Therefore, this therapy is not widely used.
Management: Is the Term NGU Obsolete?
Studies of ofloxacin and clarithromycin demonstrated efficacy equivalent to that of doxycycline for treatment of chlaOver the last decade, sensitive diagnostic tests for chlamydia infection have become widely available. The development of mydial and nonchlamydial NGU, but sample sizes were small ( [40] and personal communication, W. McCormick). The effinoninvasive urine nucleic acid amplification tests has made the screening of males feasible. The epidemiology of NGU is cacy and safety of a 7-day course of sparfloxacin were comparable to those of doxycycline in a double-blinded randomized changing, with a decline in the proportion of cases resulting from chlamydial infection, particularly in areas with well-estabmulticenter study of 725 men with clinically diagnosed NGU and §5 PMNs/hpf on urethral microscopy who were tested by lished chlamydia screening programs. The question then arises as to the need for new terminology defining urethritis, i.e., culture for N. gonorrhoeae, C. trachomatis, U. urealyticum, and M. hominis [41] . A 3-day sparfloxacin course was associgonococcal, chlamydial, and nongonococcal/nonchlamydial urethritis. ated with a lower C. trachomatis eradication rate than were both of the 7-day courses of therapy.
Differentiation between chlamydial and nonchlamydial urethritis is important because of the different public health apIn all of these studies, cure rates and relapse rates differed by etiology, although not by therapy. For example, Stamm et proaches to control, such as partner notification and management of treatment failure. However, regulatory and cost al. demonstrated 94% microbiological cure at 2 weeks, with little difference at 5 weeks' follow-up, in cases of chlamydial restrictions prohibit access in most clinical settings to gram staining and nucleic acid amplification testing. How, then, can urethritis. In contrast, the microbiological cure rates for patients with ureaplasma urethritis were lower: 71% at 2 weeks and widespread diagnostic screening for urethritis be implemented, given the reality of current limitations in most clinical settings? 53% at 5 weeks [5] . Romanowski formed. In these cases, partner referral and similar treatment treated patients with chlamydial urethritis, a high cure rate is of the partner are recommended. ensured if they are compliant with the appropriate antibiotic regimen. Conversely, for patients with nonchlamydial NGU, relapse rates can be expected to be up to 50% after 2 months.
Conclusions and Recommendations Knowledge of etiology also helps discern whether patients are
The 1998 STD treatment guidelines divide urethritis into at continued risk. For example, recurrence of chlamydial infecfour mutually exclusive categories (figure 1). tion would more likely be due to reexposure or continued high-(1) Asymptomatic. This category includes presence of subrisk activity than to treatment failure. jective symptoms, but objective evidence of inflammation is Because of the lack of availability of tests, assessment for not obtained by the documenting of discharge, a positive LET, trichomonas infection is routinely indicated only for patients or a finding of §5 WBCs/hpf on gram staining. Treatment is with urethritis (gonococcal, chlamydial, or nongonococcal/nondeferred until tests for gonorrhea and chlamydial infection are chlamydial) who do not fully respond to therapy. Many pracdone. This approach will prevent unnecessary treatment but titioners prefer to treat these patients empirically because treatwill identify cases of asymptomatic urethritis, especially if a ment with metronidazole is inexpensive.
nucleic acid amplification test is used. Among adolescents or in other groups where compliance or follow-up is especially problematic and prevalence of chlamydial/gonococcal infection isolated, since the pathogenicity in the female partner is still rion of the presence of PMNs on microscopy need to be changed if we are now isolating pathogens in asymptomatic unclear for organisms causing nonchlamydial NGU.
(4) Recurrent/persistent urethritis. Effective regimens patients who do not meet this criterion? (3) Definition and etiology of persistent urethritis. We still have not been identified for treating patients who experience persistent symptoms or frequent recurrences following treatdo not have a good understanding of the etiology and optimal management of persistent urethritis. We need randomized conment. Common sense warrants that patients with persistent or recurrent urethritis who failed to comply with their original trolled trials to give us some direction in our approach to these cases. treatment regimen or are reexposed to an untreated partner should be retreated. Directly observed single-dose therapy and (4) Operational research. The term NGU is obsolete and represents several clinical entities. What are the appropriate greater efforts toward partner management should also be considered. In addition, a wet-mount examination and culture of diagnostic and treatment paradigms? an intraurethral swab specimen for T. vaginalis should be performed, given the recent increased identification of this organ-
